Rigel Pharmaceuticals Inc (RIGL) valuation · P/E 2.7, rev $294.3M
Rigel Pharmaceuticals Inc (RIGL) P/E 2.7, rev $294.3M.
| Metric | Value |
|---|---|
| P/E | 2.7 |
| Market cap | $338.3M |
| Revenue | $294.3M |
| P/S | 1.1 |
RIGL valuation FAQ
What is RIGL's P/E ratio?
Rigel Pharmaceuticals Inc (RIGL) trailing P/E is 2.7 on the latest cached fundamentals snapshot.
What is RIGL's market cap?
Rigel Pharmaceuticals Inc (RIGL) market cap is $338.3M on the latest cached fundamentals snapshot.
What is RIGL's latest revenue?
Latest cached Rigel Pharmaceuticals Inc (RIGL) revenue was $294.3M. Statements: https://lician.com/financials/rigl
What is RIGL's price-to-sales ratio?
Rigel Pharmaceuticals Inc (RIGL) price-to-sales (P/S) is 1.1, cached market cap $338.3M divided by revenue $294.3M.
How many RIGL valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Rigel Pharmaceuticals Inc (RIGL): P/E, Market cap, Revenue, and P/S.
Where is RIGL valuation listed?
Cached valuation multiples for Rigel Pharmaceuticals Inc (RIGL) are listed at https://lician.com/valuation/rigl.
Not investment advice. Cached rows, not a live tape.